Drug Development Lessons Learned
This is a practical guide to building a lessons learned for a drug development project — what went well and badly, captured to improve future projects, adapted to the realities of developing a pharmaceutical product through regulatory stages.
What a Lessons Learned is
A lessons learned is what went well and badly, captured to improve future projects. For the full concept and how it works in general, see Lessons Learned. On a drug development project it plays the same role, tuned to this kind of work.
Why it matters for a Drug Development project
Drug Development projects live or die on developing a pharmaceutical product through regulatory stages. A well-built lessons learned gives the team a shared, explicit reference for exactly that — reducing ambiguity, aligning stakeholders, and making problems visible early enough to act. Skipping it, or doing it generically, is how drug development projects drift into avoidable delay and cost.
What to include
- What happened
- Impact
- Root cause
- Recommendation
Drug Development-specific considerations
Tailor the lessons learned to the risks that most often derail drug development projects:
- Regulatory approval delays
- Trial/validation failures
- Strict GxP compliance
Example
On a real drug development project, the lessons learned would be shaped by developing a pharmaceutical product through regulatory stages. In particular, it should explicitly account for the project’s biggest risks — regulatory approval delays, trial/validation failures, strict GxP compliance — rather than treating them as afterthoughts.